NDC 50419-348 – Ultravist

Iopromide 370 mg/mL · Injection · Intra-arterial, Intravenous

Human Prescription Drug

Product NDC50419-348

Product details

Brand name
Ultravist
Generic name
iopromide
Labeler
Bayer HealthCare Pharmaceuticals Inc.
Dosage form
Injection
Route
Intra-arterial, Intravenous
Marketing category
NDA · NDA020220
Marketed since
June 8, 2022
Listing expires
December 31, 2027
Pharmacologic class
Radiographic Contrast Agent

Active ingredients

Uses, dosage, side effects and warnings for Ultravist →

Package NDC codes (7)

Package NDCDescriptionSince
50419-348-0510 VIAL, GLASS in 1 CARTON (50419-348-05) / 50 mL in 1 VIAL, GLASSJun 8, 2022
50419-348-10100 mL in 1 VIAL, GLASS (50419-348-10)Jun 8, 2022
50419-348-11100 mL in 1 VIAL, GLASS (50419-348-11)Jun 8, 2022
50419-348-1210 VIAL, GLASS in 1 CARTON (50419-348-12) / 100 mL in 1 VIAL, GLASSJun 8, 2022
50419-348-1310 VIAL, GLASS in 1 CARTON (50419-348-13) / 100 mL in 1 VIAL, GLASSJun 8, 2022
50419-348-20200 mL in 1 VIAL, GLASS (50419-348-20)Jun 8, 2022
50419-348-2110 VIAL, GLASS in 1 CARTON (50419-348-21) / 200 mL in 1 VIAL, GLASSJun 8, 2022

Other Ultravist products